The Intersection of Viral Hepatitis and the Opioid Epidemic

Charleston, WV US
September 9, 2019

The goal of this course module is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, understand HCV screening recommendations, current treatment options, and specific issues with vulnerable populations especially people who inject drugs, the opioid use disorder.

Target Audience

This program is directed to primary care physicians, specialists (ID, Gastro, Hepatology), nurses, public health, Drug and Alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Hepatitis C particularly people who use drugs.

 

Learning Objectives

Performance

Increase HCV testing (national average is 48%, goal is 66%) in Pennsylvania

Competency

Successful linkage to HCV care will increase. Providers will understand the intersection of the three epidemics (OUD, OD, ID)

Increase Knowledge

Understand the effectiveness and efficacy of harm reduction strategies for community health.

Course summary
Available credit: 
  • 6.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.25 Attendance
Course opens: 
09/09/2019
Course expires: 
12/31/2019
Event starts: 
09/09/2019 - 8:00am
Event ends: 
09/09/2019 - 5:00pm

8:00 a.m.

Breakfast/Registration

 

Naloxone Training

Clayton Ruley, M.S.S., M.L.S.P.

Director, Community Engagement and Volunteer Services

 

8:50 a.m.

Welcome

Suzanna Masartis

Community Liver Alliance

 

9:00 a.m. – 9:30 a.m.

Viral Hepatitis in Pennsylvania

Lauren Orkis, DrPH

Viral Hepatitis Coordinator

PA Department of Health

 

9:30 a.m. – 10:00 a.m.

Viral Hepatitis in Philadelphia

Danica Kuncio, MPH

Viral Hepatitis Program Manager

Philadelphia Department of Health

 

10:00 a.m. -10:30 a.m.

Hepatocellular Cancer Screening in 2019

Kenneth Rothstein, MD

UPenn Health System

 

10:30 a.m. - 11:00 a.m.

Community Based Screening and a Public Health Approach

Catherine Freeland, MPH

Public Health Program Manager

Hep B Foundation

 

11:00 a.m. – 11:30 a.m.

The Role of Criminal Justice

Paul Noel, MD

Chief, Clinical Services

PA Department of Corrections, BHCS

 

11:30 a.m. – 12:00 p.m.

Harm Reduction Strategies – More than a Needle Exchange

Devin Reaves, MSW

Executive Director

PA Harm Reduction Coalition

 

Clayton Ruley, M.S.S., M.L.S.P.

Director of Community Engagement and Volunteer Services

Prevention Point Philadelphia

 

Tracey Esteves-Camacho

Director of Social Services

Prevention Point Philadelphia

 

 

 

 

Lunch and Keynote Speaker

12:10 p.m.- 12:50 p.m.

Pennsylvania Viral Hepatitis Elimination Update

Stacey Trooskin, MD

Philadelphia FIGHT Community Health Centers

 

Breakout Sessions

1:00 p.m. – 1:50 p.m.

Harm Reduction Strategies for Providers

Devin Reaves, MSW

Executive Director

PA Harm Reduction Coalition

 

Clayton Ruley, M.S.S., M.L.S.P.

Director of Community Engagement and Volunteer Services

Prevention Point Philadelphia

 

Tracey Esteves-Camacho

Director of Social Services

Prevention Point Philadelphia

 

Post Incarceration Care – The AIDS Care Group Model

Jim Ealy, MA.

Education/Outreach Director

HCV Cure Program Director

AIDS Care Group

 

Treating the Virus is the Easy Part

Joanne Gilmore, MSN, ANP-BC

Prevention Point Philadelphia

 

Breakout Sessions

2:00 p.m. – 2:50 p.m.     

Viral Hepatitis B and C and HIV Co-Infection in special populations

Jay Kostman, MD

Medical Director

Philadelphia FIGHT Community Health Centers

 

Navigating Patients to a Cure for Viral Hepatitis B and C

Hannah Zellman, MSW

Program Manager for C Change at the Health Federation of Philadelphia

 

Wilfredo Laboy, C Change

Health Federation of Philadelphia

 

Ta-Wanda Preston, C A Difference

Philadelphia FIGHT Community Health Centers

 

Ricardo Rivera, C A Difference

Philadelphia FIGHT Community Health Centers

 

Jessica Santiago, C Change

Health Federation of Philadelphia

 

Medication Access and Patient Counseling

David Koren, PharmD

Temple University Health System

 

3:00 p.m. – 3:30 p.m.

How Do We Get Ahead of the Epidemic Wrap Up

Jose Benitez, MSW, FCPP

Executive Director

Prevention Point Philadelphia

 

3:30 - 4:00 p.m.

HCV/HIV Rapid Screening Training

Rebecca Parsons

OraSure Technologies

 

4:00 p.m.

Adjourn

Charleston Colliseum and Convention Center
200 Civic Center Dr.
Charleston, WV 25301
United States

All individuals in a position to control the content of this education activity including  members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed  all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.

 

The following relevant financial relationships were disclosed:

Kenneth Rothstein, MD - Consultant for Abbvie.

Stacey Trooskin, MD – Grant Research from Gilead Sciences.

Hannah Zellman, MSW – Grant Research from Gilead Sciences.

Jessica Santiago – Grant Research from Gilead Sciences.

David Koren, MPh – Grant Research from Gilead Sciences, Consultant Gilead Sciences.

Chari Cohen – Grant Research for Gilead Sciences, Arbutus Biopharm, Eiger Biosciences, Quest D.

Wilfredo Laboy – Grant Research for Gilead Sciences.

 

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and Community Liver Alliance. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 6.25 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.25 Attendance

Accreditation Period

Course opens: 
09/09/2019
Course expires: 
12/31/2019
Please login or register to take this course.